Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.38 USD | +0.31% | -2.86% | -21.36% |
06:57pm | Bristol-Myers Squibb Says Breyanzi Gets FDA Approval as CAR T Cell Therapy for Mantle Cell Lymphoma | MT |
06:22pm | Bristol Myers: FDA approval for Breyanzi | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.36% | 81.59B | |
+39.87% | 731B | |
+31.34% | 586B | |
-7.16% | 348B | |
+14.48% | 319B | |
+0.65% | 273B | |
+13.47% | 235B | |
-6.63% | 203B | |
+7.49% | 202B | |
+5.02% | 159B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Insider Trends: Insider Acquires Bristol-Myers Squibb Stock Via Option/Derivative Security, Sells Part to Pay Tax, Trend of Selling Intact